Talking Precision Medicine

The Science and Art of De-risking Cancer Drug Development | Talking Precision Medicine #35

Listen Later

In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger, head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies.

Episode 35 links:

  • Visit ⁠⁠⁠TPM E35⁠⁠⁠ for highlights and links from this episode >
  • Learn more about Genialis™ krasID >
  • New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients >



    • ...more
    View all episodesView all episodes
    Download on the App Store
    Talking Precision MedicineBy Genialis
    • 4.7
    • 4.7
    • 4.7
    • 4.7
    • 4.7

    4.7

    7 ratings

    More shows like Talking Precision Medicine

    View all
    Science Weekly by The Guardian

    Science Weekly

    418 Listeners

    Freakonomics Radio by Freakonomics Radio + Stitcher

    Freakonomics Radio

    32,140 Listeners

    TED Radio Hour by NPR

    TED Radio Hour

    21,947 Listeners

    Hidden Brain by Hidden Brain, Shankar Vedantam

    Hidden Brain

    43,713 Listeners

    Pivot by New York Magazine

    Pivot

    9,583 Listeners

    The Daily by The New York Times

    The Daily

    112,571 Listeners

    The Journal. by The Wall Street Journal & Spotify Studios

    The Journal.

    6,011 Listeners

    All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

    All-In with Chamath, Jason, Sacks & Friedberg

    9,790 Listeners

    BioCentury This Week by BioCentury

    BioCentury This Week

    32 Listeners

    Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

    Biotech Hangout

    20 Listeners